top of page

FRCPath Haem Part 1 MCQ-Oncology 219

A 66-yr-old pt presents with lymphadenopathy and anaemia due to CLL. His FISH shows del(17p) and TP53 mutation. Which of following is best ist line?

  • venetoclax–obinutuzumab

  • venetoclax–Rituximab

  • Acalabrutinib

  • FCR


 
 
 

1 Comment


adwaan567
Nov 03

Correct Answer: Acalabrutinib


Please read BSH Guidelines: https://doi.org/10.1111/bjh.70100


ree

Like
bottom of page